Prevalence of type-specific human papillomavirus and pap results in Chinese women: A multi-center, population-based cross-sectional study

Cancer Causes and Control

Volumn 24, Issue 4, 2013, Pages 795-803

  Wu, En Qi ^a   Liu, Bin ^a   Cui, Jian Feng ^a   Chen, Wen ^a   Wang, Jian Bing ^a   Lu, Liang ^a   Niyazi, Mayineur ^b   Zhao, Chao ^c   Ren, Sheng Da ^d   Li, Chang Qing ^e   Gong, Xiang Zhen ^f   Smith, Jennifer S ^g   Belinson, Jerome L ^h   Liaw, Kai Li ⁱ   Velicer, Christine ⁱ   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d Xiangyuan Women and Children Hospital   (China)

^e Xinmi Women and Children Hospital   (China)

^f Disease Control and Prevention Center in Hongkou District   (China)

^g IL   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cervical cancer; China; Human papillomavirus; Population based study; Type specific prevalence

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; CROSS-SECTIONAL STUDIES; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84876463116     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0162-8     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893. doi: 10.1002/ijc.25516
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. (2010) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
3. Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL (2011) Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine 29(13):2487-2494. doi: 10.1016/j.vaccine.2010.12.085
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12-19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F
5. zur Hausen H (1999) Papillomaviruses in human cancers. Proc Assoc Am Phys 111(6):581-587
6. Bioscience Division, Los Alamos National Laboratory, the Regents of the University of California. HPV sequence database: PV types and hosts -database online Available at: http://hpv-web.lanl.gov/stdgen/virus/cgi-bin/hpv-organisms. cgi?dbname-hpv Accessed August 23, 2004
7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17-27. doi: 10.1016/j.virol.2004.03.033
8. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527. doi: 10.1056/NEJMoa021641
9. Garland S, Park SN, Ngan HY, Frazer I, Tay EH, Chen CJ, Bhatla N, Pitts M, Shin HR, Konno R, Smith J, Pagliusi S, Park JS (2008) The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference. Vaccine 26(43):5435-5440. doi: 10.1016/j.vaccine.2008.07. 077
10. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G (2006) Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18 follow-up from a randomised control trial. Lancet 367(9518):1247-1255
11. The FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 (19):1915-1927. doi: 10.1056/NEJMoa061741
12. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121(3):621-632. doi: 10.1002/ijc.22527
13. China national cause-of-death surveys. China Cancer Database Web site. Available at http://cancernet.cicams.ac.cn/data/epi/census
14. Stephen AL, Thompson CH, Tattersall MH, Cossart YE, Rose BR (2000) Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86(5):695-701. doi: 10.1002/(SICI)1097-0215(20000601)86:5<695:AID-IJC15>3.0.CO;2-C
15. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2009). World population prospects: The 2008 Revision. Highlights. New York: United Nations. Available from http://www.un.org/esa/population
16. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202(12):1789-1799. doi: 10.1086/657321
17. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S (2006) Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 95(1):96-101. doi: 10.1038/sj.bjc.6603208
18. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S (2007) Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 121(6):1306-1311. doi: 10.1002/ijc.22726
19. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S (2006) Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 95(11):1593-1597. doi: 10.1038/sj.bjc.6603450
20. Lin M, Yang LY, Li LJ, Wu JR, Peng YP, Luo ZY (2008) Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province. Aust N Z J Obstet Gynaecol 48(2):189-194. doi: 10.1111/j.1479-828X.2008.00844.x
21. Ye J, Cheng X, Chen X, Ye F, Lu W, Xie X (2010) Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J 7:66. doi: 10.1186/1743-422X-7-66
22. Munoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Munoz A (2004) Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 190(12):2077-2087. doi: 10.1086/425907
23. Dutra I, Santos MR, Soares M, Couto AR, Bruges-Armas M, Teixeira F, Monjardino L, Hodgson S, Bruges-Armas J (2008) Characterisation of human papillomavirus (HPV) genotypes in the Azorean population Terceira island. Infect Agent Cancer 3:6. doi: 10.1186/1750-9378-3-6
24. Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J, Zhu L, Zhang YP, Li H, Gu YS, Liu XZ (2009) Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. Br J Cancer 101(9):1635-1640. doi: 10.1038/sj.bjc.6605351
25. Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40(3):902-907
26. Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM, To KF, Wong YF, Cheung JL, Chan DP, Hui M, Ip M (2006) Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118(1):243-245. doi: 10.1002/ijc.21299
27. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453-459. doi: 10.1016/S1473-3099(07)70158-5
28. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste Costa Rica. J Infect Dis 191(11):1796-1807. doi: 10.1086/428850
29. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E (2004) Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57(1):68-72